Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Renold agrees to £187m takeover from Webster Industries

(Sharecast News) - Industrial chain manufacturer Renold has reached an agreement regarding a £187m takeover from private equity firm Morgenthaler Private Equity, causing shares to surge on Friday. Last month, the company revealed that it had received two takeover proposals - one from a consortium comprising Buckthron Partners and One Equity Partners at 81p per share, and the other from Ohio-based Webster Industries, a company majority-owned by a fund managed and controlled by MPE, at 77p per share.

MPE has since sweetened its bid to 82p, representing a 50% premium to Renold's closing price before offer talks were reported, which Renold's board has now agreed to.

Renold chair David Landless said the offer "not only represents a significant premium and provides shareholders with the certainty of a cash consideration but also provides an opportunity to deliver on our strategy more quickly".

MPE said in a statement that Renold's portfolio or applications and engineering capabilities makes it "a natural fit with Webster", which specialises in engineered conveying, feeding, separation, screening and steel levelling solutions.

"MPE believes that Renold, under private ownership and when combined with Webster, will benefit from a broader long-term strategic focus and an optimised capital structure. MPE is committed to supporting Renold's management team in accelerating the company's growth trajectory, investing in innovation, and unlocking its full potential," the private equity firm said.

Renold shares were 8.7% higher at 82.6p by 0832 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.